Skip to main content

Six-Month Mortality Lower With Liberal Transfusion Strategy in Acute MI With Anemia

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 6, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 6, 2025 -- For patients with acute myocardial infarction (MI) and anemia, the primary outcome of 30-day mortality or MI does not differ with a restrictive versus liberal transfusion strategy, but a restrictive transfusion strategy is associated with increased all-cause mortality at six months, according to research published online Dec. 23 in NEJM Evidence.

Jeffrey L. Carson, M.D., from the Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, and colleagues examined the effect of restrictive versus liberal blood transfusion strategies in patients with acute MI and anemia. Patients were randomly assigned to a restrictive (transfusion threshold of 7 to 8 g/dL) or liberal (transfusion threshold of 10 g/dL) red cell transfusion strategy; data were included for 4,311 patients from four trials.

The researchers found that the primary outcome (composite of 30-day mortality or MI) occurred in 15.4 and 13.8 percent of patients in the restrictive strategy and liberal strategy groups, respectively (relative risk [RR], 1.13; 95 percent confidence interval [CI], 0.97 to 1.30). Death at 30 days occurred in 9.3 and 8.1 percent of patients in the restrictive and liberal strategy groups, respectively (RR, 1.15; 95 percent CI, 0.95 to 1.39), while cardiac death at 30 days occurred in 5.5 and 3.7 percent, respectively (RR, 1.47; 95 percent CI, 1.11 to 1.94). No significant difference was seen in heart failure between the transfusion strategy groups. All-cause mortality at six months occurred in 20.5 and 19.1 percent of patients in the restrictive and liberal strategy groups (hazard ratio, 1.08; 95 percent CI, 1.05 to 1.11).

"Giving more blood to anemic patients with heart attacks can save lives at six months," Carlson said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Read this next

Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction

MONDAY, April 28, 2025 -- For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial, according to a study published online in...

Maternal Anemia in Early Pregnancy May Increase Risk for Congenital Heart Disease

WEDNESDAY, April 23, 2025 -- Maternal anemia in early pregnancy is associated with an increased risk for congenital heart disease (CHD) in offspring, according to a study...

ACC: Cannabis Use Linked to Increased Risk for MI in People Aged 50 Years and Younger

TUESDAY, March 18, 2025 -- Cannabis use is associated with an increased risk for adverse cardiovascular events, including myocardial infarction (MI), according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.